THE NATIONAL ACADEMIES OF SCIENCES, ENGINEERING, AND MEDICINE
Division on Earth and Life Studies
Board on Chemical Sciences and Technology
Committee to Identify Innovative Technologies to Advance Pharmaceutical Manufacturing
*****
Congressional Briefings
Friday, March 5, 2021 – 11:00 a.m.
and
Tuesday, March 16, 2021 -- 11:00 a.m.
via Zoom
on
Innovations in Pharmaceutical Manufacturing on the Horizon: Technical Challenges, Regulatory Issues, and Recommendations
This new report, from the National Academies of Sciences, Engineering, and Medicine, identifies emerging technologies - such as product technologies, manufacturing processes, control and testing strategies, and platform technologies - that have the potential to advance pharmaceutical quality and modernize pharmaceutical manufacturing for products regulated by the Center for Drug Evaluation and Research of the FDA. This report describes many innovations to modernize the manufacture of drug substances and drug products, to advance new control approaches, and to develop integrated, flexible, and distributed manufacturing networks within 5-10 years.
These briefings were for members of Congress and congressional staff only. The report was publicly released on February 24, 2021 and can be found, in its entirety, on the Web site of the National Academies Press.